Metraipolis › archive › dc_eaa34375489e

From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents — Europe PMC PMID:42352904

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42352904
DOI
10.3390/ijms27125179
License (as archived)
solo-consultazione
Archived
2026-10-31T16:42:22.562Z
SHA-256 of the archived text
74963006daddc2e68b4dd1d7d098d2688e1b26d68eab2d91e8b86a3090476a2e
Stable URL of this page
https://metraipolis.com/documento/dc_eaa34375489e

How to cite

From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents — Europe PMC PMID:42352904 — Europe PMC (en), https://europepmc.org/article/MED/42352904 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa34375489e (Metraipolis archive dc_eaa34375489e, sha256 74963006daddc2e68b4dd1d7d098d2688e1b26d68eab2d91e8b86a3090476a2e)
BibTeX
@misc{dceaa34375489e,
  title = {From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents — Europe PMC PMID:42352904},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42352904},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa34375489e; sha256 74963006daddc2e68b4dd1d7d098d2688e1b26d68eab2d91e8b86a3090476a2e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42352904. Agents can read the archived copy with the MCP tool read_document.